Nur Samsu
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Renal Diseases and Glomerulopathies 4
- Chronic Kidney Disease and Diabetes 3
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Sri Masyeni (2 shared papers)Muhammad Ilmawan (2 shared papers)Ali A. Rabaan (2 shared papers)Marhami Fahriani (2 shared papers)Syahrul Syahrul (2 shared papers)Harapan Harapan (2 shared papers)Sukamto S. Mamada (2 shared papers)Jonny Karunia Fajar (3 shared papers)
- Journals
- F1000Research (2 papers)Biomedicines (1 paper)Diabetes Metabolic Syndrome and Obesity (1 paper)Lupus Science & Medicine (1 paper)BioMed Research International (1 paper)
- Partner nations
- IndonesiaSaudi ArabiaBangladesh
In The Last Decade
Nur Samsu
17 papers receiving 678 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Nephrology 195
- Clinical Biochemistry 99
- Endocrinology, Diabetes and Metabolism 141
- Complementary and alternative medicine 36
- Cancer Research 64
Countries citing papers authored by Nur Samsu
This map shows the geographic impact of Nur Samsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nur Samsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nur Samsu more than expected).
Fields of papers citing papers by Nur Samsu
This network shows the impact of papers produced by Nur Samsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nur Samsu. The network helps show where Nur Samsu may publish in the future.
Co-authors
The 22 scholars most cited alongside Nur Samsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment Hit paper breakdown → | 2021 | 587 |
| 2 | 2020 | 28 | |
| 3 | 2021 | 24 | |
| 4 | 2015 | 12 | |
| 5 | 2022 | 7 | |
| 6 | 2019 | 6 | |
| 7 | 2017 | 4 | |
| 8 | 2025 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 1967 | 3 | |
| 11 | Profil Kejadian Bakteriuria Asimtomatik serta Faktor-Faktor yang Terkait dengan Kejadian Bakteriuria Asimtomatik pada Ibu Hamil di Puskesmas Janti Kota Malang | 2016 | 3 |
| 12 | 2020 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2018 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2020 | 0 |
About Nur Samsu
Nur Samsu is a scholar working on Nephrology, Infectious Diseases, Surgery, Neurology and Public Health, Environmental and Occupational Health, having authored 26 papers that have together received 689 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Renal Diseases and Glomerulopathies (4 papers), Long-Term Effects of COVID-19 (3 papers), Chronic Kidney Disease and Diabetes (3 papers), Advanced Glycation End Products research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Systemic Lupus Erythematosus Research (2 papers) and COVID-19 and Mental Health (2 papers). The work is most often cited by research in Nephrology (195 citations), Clinical Biochemistry (99 citations), Endocrinology, Diabetes and Metabolism (141 citations), Complementary and alternative medicine (36 citations) and Cancer Research (64 citations). Nur Samsu has collaborated with scholars based in Indonesia, Saudi Arabia and Bangladesh. Frequent co-authors include Sri Masyeni, Muhammad Ilmawan, Ali A. Rabaan, Marhami Fahriani, Syahrul Syahrul, Harapan Harapan, Sukamto S. Mamada, Jonny Karunia Fajar, Talha Bin Emran and Ichsan Ichsan. Their work appears in journals such as F1000Research, Biomedicines, Diabetes Metabolic Syndrome and Obesity, Lupus Science & Medicine and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.